In Vitro Properties of a High Affinity Selective Antagonist of the VIP1 Receptor
- 31 December 1997
- Vol. 18 (10) , 1555-1560
- https://doi.org/10.1016/s0196-9781(97)00230-1
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Pharmacological properties of two recombinant splice variants of the PACAP type I receptor, transfected and stably expressed in CHO cellsEuropean Journal of Pharmacology: Molecular Pharmacology, 1995
- Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributionsEndocrinology, 1994
- Human Intestinal VIP Receptor: Cloning and Functional Expression of Two cDNA Encoding Proteins with Different N-Terminal DomainsBiochemical and Biophysical Research Communications, 1994
- The VIP2 receptor: Molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptideFEBS Letters, 1993
- Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptideNeuron, 1992
- Ac-Tyr1hGRF discriminates between VIP receptors from rat liver and intestinal epitheliumLife Sciences, 1989
- A fragment of vasoactive intestinal peptide, VIP(10–28), is an antagonist of VIP in the colon carcinoma cell line, HT29Peptides, 1986
- Interaction of PHM, PHI and 24-glutamine PHI with human VIP receptors from colonic epithelium: Comparison with rat intestinal receptorsLife Sciences, 1985
- Structural requirements for VIP interaction with specific receptors in human and rat intestinal membranes: Effect of nine partial sequencesBiochemical and Biophysical Research Communications, 1984
- Interaction of GRF with VIP receptors and stimulation of adenylate cyclase in rat and human intestinal epithelial membranesFEBS Letters, 1983